TA Associates invests in AIRS Medical to fund global expansion of MRI AI
AI medical imaging company AIRS Medical, whose software speeds MRI scans, receives a strategic growth investment from TA Associates.
AIRS Medical, a developer of AI software for MRI acceleration and image reconstruction, announced a strategic growth investment from TA Associates, a global private equity firm. The company said the capital will support its international expansion, its AI radiology technology and product innovation.
AIRS Medical was founded in 2018 and says its AI technologies are used in more than 6 million MRI examinations a year. Co-Founder and Chairman Hyeseong Lee and CEO Jason Park said the partnership will help widen access to advanced diagnostics. Edward Sippel, Managing Director and head of TA Asia Pacific, said the company's international footprint positions it to meet growing demand. Financial terms were not disclosed.
Deal facts
- Target
- AIRS Medical
- Business
- Develops AI-native MRI acceleration and reconstruction software, including SwiftMR and SwiftSight, used by more than 1,700 healthcare institutions in over 40 countries.
- Investor
- TA Associates
- Sponsor
- TA Associates
- Deal type
- Investment
- Status
- Announced
- Announced
- Tuesday, June 16, 2026
Sources
- Business WireJun 16, 2026
Written by Buyout Desk from the sources above. Spotted an error? Email corrections@buyoutdesk.com.